Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease
Journal of Parkinson s Disease (2014) - Comments
pubmed: 24662192  doi: 10.3233/jpd-140364  issn: 1877-718x  issn: 1877-7171 

Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Joshua Kahan, Peter Ell Fmedsci, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees, Patricia Limousin, Thomas Foltynie